The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial
Open accessAbstract
Background: Acute kidney injury (AKI) is an important complication encountered during the course of diabetic ketoacidosis (DKA). Plasma-Lyte with lower chloride concentration than saline has been shown to be associated with reduced incidence of AKI in adults with septic shock. No study has compared this in DKA. Methods: This double-blind, parallel-arm, investigator-initiated, randomized controlled trial compared 0.9% saline with Plasma-Lyte-A as initial fluid in pediatric DKA. The study was done in a tertiary care, teaching, and referral hospital in India in children (> 1 month–12 years) with DKA as defined by ISPAD. Children with cerebral edema or known chronic kidney/liver disease or who had received pre-referral fluids and/or insulin were excluded. Sixty-six children were randomized to receive either Plasma-Lyte ( n = 34) or 0.9% saline ( n = 32). Main outcomes: Primary outcome was incidence of new or progressive AKI, defined as a composite outcome of change in creatinine (defined by KDIGO), estimated creatinine clearance (defined by p-RIFLE), and NGAL levels. The secondary outcomes were resolution of AKI, time to resolution of DKA (pH > 7.3, bicarbonate> 15 mEq/L & normal sensorium), change in chloride, pH and bicarbonate levels, proportion of in-hospital all-cause mortality, need for renal replacement therapy (RRT), and length of ICU and hospital stay. Results: Baseline characteristics were similar in both groups. The incidence of new or progressive AKI was similar in both [Plasma-Lyte 13 (38.2%) versus 0.9% saline 15 (46.9%); adjusted OR 1.22; 95% CI 0.43–3.43, p = 0.70]. The median (IQR) time to resolution of DKA in Plasma-Lyte-A and 0.9% saline were 14.5 (12 to 20) and 16 (8 to 20) h respectively. Time to resolution of AKI was similar in both [Plasma-Lyte 22.1 versus 0.9% saline 18.8 h (adjusted HR 1.72; 95% CI 0.83–3.57; p = 0.14)]. Length of hospital stay was also similar in both [Plasma-Lyte 9 (8 to 12) versus 0.9% saline 10 (8.25 to 11) days; p = 0.39]. Conclusions: The incidence of new or progressive AKI and resolution of AKI were similar in both groups. Plasma-Lyte-A was similar to 0.9% Saline in time to resolution of DKA, need for RRT, mortality, and lengths of PICU and hospital stay. Trial registration: Clinical trial registry of India, CTRI/2018/05/014042 ( ctri.nic.in ) (Retrospectively registered).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balanced crystalloids versus saline in critically ill adults.
Semler, M. W., Self, W. H., Wanderer, J. P., Ehrenfeld, J. M., Wang, L., Byrne, D. W., Stollings, J. L., Kumar, A. B., Hughes, C. G., Hernandez, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711584 · Cited by 1,433
Yunos, N. M., Bellomo, R., Hegarty, C., Story, D., Ho, L., & Bailey, M. (2012) · JAMA · doi:10.1001/jama.2012.13356 · Cited by 1,210
Balanced Crystalloids versus Saline in Noncritically Ill Adults
Self, W. H., Semler, M. W., Wanderer, J. P., Wang, L., Byrne, D. W., Collins, S. P., Slovis, C. M., Lindsell, C. J., Ehrenfeld, J. M., Siew, E. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711586 · Cited by 1,155
Young, P., Bailey, M., Beasley, R., Henderson, S., Mackle, D., McArthur, C., McGuinness, S., Mehrtens, J., Myburgh, J., Psirides, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.12334 · Cited by 728
The risk and outcome of cerebral oedema developing during diabetic ketoacidosis
Edge, J. A., Hawkins, M. M., Winter, D. L., & Dunger, D. B. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.1.16 · Cited by 368
Bench-to-bedside review: Chloride in critical illness
Yunos, N., Bellomo, R., Story, D., & Kellum, J. (2010) · Critical Care · doi:10.1186/cc9052 · Cited by 325
Diabetic ketoacidosis in children and adolescents with diabetes
Wolfsdorf, J., Craig, M. E., Daneman, D., Dunger, D., Edge, J., Lee, W., Rosenbloom, A., Sperling, M., & Hanas, R. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00569.x · Cited by 313
Krajewski, M. L., Raghunathan, K., Paluszkiewicz, S. M., Schermer, C. R., & Shaw, A. D. (2015) · Journal of British Surgery · doi:10.1002/bjs.9651 · Cited by 295
Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial.
Semler, M. W., Wanderer, J. P., Ehrenfeld, J. M., Stollings, J. L., Self, W. H., Siew, E. D., Wang, L., Byrne, D. W., Shaw, A. D., Bernard, G. R., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1345oc · Cited by 249
Diabetic Ketoacidosis: Risk Factors and Management Strategies
Umpierrez, G. E., & Kitabchi, A. E. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00003 · Cited by 204
Research works printed but not linked: 3
- Jayashree M, Sasidharan R, Singhi S, Nallasamy K, Baalaaji M. Root cause analysis of diabetic ketoacidosis admissions at a tertiary referral pediatric emergency department in North India. Indian J Endocrinol Metab. 2017;21:710. · doi:10.4103/ijem.ijem_178_17
- Moulik NR, Jayashree M, Singhi S, Bhalla AK, Attri S. Nutritional status and complications in children with diabetic ketoacidosis. Pediatr Crit Care Med. 2012;13:e227–33. · doi:10.1097/pcc.0b013e31823c9a11
- Baalaaji M, Jayashree M, Nallasamy K, Singhi S, Bansal A. Predictors and outcome of acute kidney injury in children with diabetic ketoacidosis. Indian Pediatr. 2018;55:311–4. · doi:10.1007/s13312-018-1274-8
Cited by
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
COVID-19: breaking down a global health crisis
Mallah, S. I., Ghorab, O. K., Al-Salmi, S., Abdellatif, O. S., Tharmaratnam, T., Iskandar, M. A., Sefen, J. A. N., Sidhu, P., Atallah, B., El-Lababidi, R., et al. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00438-7 · Cited by 363
Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24360-w · Cited by 247
Halperin, I. J., Wicklow, B., Amed, S., Chambers, A., Courage, C., Cummings, E., Kirkland, P., MacKay, D., Nakhla, M., Punthakee, Z., et al. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2025.01.001 · Cited by 22
Metadata
- Authors
- Williams, V., Jayashree, M., Nallasamy, K., Dayal, D., & Rawat, A.
- Venue
- Critical Care
- Published
- 2020-01-02
- Volume
- 24
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W3004157670
- Cited by
- 253
- References
- 29
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Indian Council of Medical Research (3/2/Jan.2017/PG-Thesis-HRD (13))
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial. https://app.cochat.ai/papers/10.1186/s13054-019-2683-3
- The paper
- Williams, V., Jayashree, M., Nallasamy, K., Dayal, D., & Rawat, A. (2020). 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial. Critical Care. https://doi.org/10.1186/s13054-019-2683-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.